Canadian medical reactor gets nod to restart

Jul 07, 2010

Canada's nuclear safety commission authorized Wednesday the restarting of a reactor that produced one-third of the world's supply of medical isotopes before it closed for repairs last year.

The half-century old National Research Universal reactor in Chalk River, Ontario, 185 kilometers (115 miles) northwest of Ottawa, could be restarted at the end of the month.

It was shut down in May 2009 after a leak of inside the reactor.

Atomic Energy of Canada Limited (AECL) had initially estimated the stoppage would last only a few months.

produced by the are used to diagnose cancer and heart disease in patients around the world. The shutdown led to a global shortage of the precious radioactive material.

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Rebooting of Canadian medical isotope reactor delayed

Aug 13, 2009

A Canadian reactor that produced one-third of the world's supply of medical isotopes before it closed in May for repairs will remain offline at least until early 2010, nuclear authorities said Thursday.

A top supplier of medical isotopes closed through 2009

Jul 08, 2009

An aging Canadian nuclear reactor responsible for production of one-third of the isotopes used in medical radiation treatment around the world will be out of service through at least the end of 2009, authorities said Wednesday.

Officials seek cause of reactor shutdown

Nov 03, 2006

Authorities are investigating the cause of the nuclear reactor shutdown at Three Mile Island near Harrisburg, Pa., although no radiation leaked in the incident.

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Sensors may keep hospitalized patients from falling

(Medical Xpress)—To keep hospitalized patients safer, University of Arizona researchers are working on new technology that involves a small, wearable sensor that measures a patient's activity, heart rate, ...

Fresh hope for preventing pneumonia in the elderly

There are calls for the frail and elderly not be be overlooked for vaccines against pneumonia this winter, with UNSW research challenging conventional wisdom on immunisation effectiveness in older patients.

Phase transiting to a new quantum universe

(Phys.org) —Recent insight and discovery of a new class of quantum transition opens the way for a whole new subfield of materials physics and quantum technologies.

Imaging turns a corner

(Phys.org) —Scientists have developed a new microscope which enables a dramatically improved view of biological cells.

NASA image: Volcanoes in Guatemala

This photo of volcanoes in Guatemala was taken from NASA's C-20A aircraft during a four-week Earth science radar imaging mission deployment over Central and South America. The conical volcano in the center ...